Literature DB >> 1702721

Glycosylation of CD45: carbohydrate composition and its role in acquisition of CD45R0 and CD45RB T cell maturation-related antigen specificities during biosynthesis.

R Pulido1, F Sánchez-Madrid.   

Abstract

The contribution of oligosaccharides to the biochemical composition and antigen heterogeneity of the phosphotyrosine phosphatase CD45 glycoproteins has been studied on the K-562 erythroleukemic cell line. Treatment of immunoprecipitated CD45 glycoproteins with distinct exo- and endoglycosidases revealed the presence of highly sialylated O- and N-linked complex carbohydrates in the composition of mature CD45 glycoproteins. Incubation of K-562 cells with the N-glycosylation inhibitor tunicamycin blocked carbohydrate processing during biosynthesis of CD45 proteins, generating unglycosylated polypeptides similar in size to those resulting from digestion of CD45 proteins with a mixture of both N- and O-glycanases. Epitopes defining the T cell maturation related CD45R0 and CD45RB antigen specificities were present on the mature 180- and 190-kDa K-562 CD45 proteins, respectively. However, the CD45R0 and CD45RB epitopes were not detected on the high mannose biosynthetic CD45 precursors. Furthermore, treatment of CD45 proteins with O-glycanase or neuraminidase resulted in the loss of both CD45R0 and CD45RB epitopes, although reactivity of the anti-CD45R0 and anti-CD45RB mAb was not affected by mAb preincubation with either sialic acids or sialyllactose in solution. From these results we conclude that the blockade of early steps of N-glycosylation during carbohydrate processing resulted in the inhibition of subsequent incorporation of O-linked sugars on CD45 polypeptides, thus preventing the late acquisition of the CD45R0 and CD45RB determinants on the 180- and 190-kDa CD45 polypeptides.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1702721     DOI: 10.1002/eji.1830201221

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  Expression of soluble isoforms of rat CD45. Analysis by electron microscopy and use in epitope mapping of anti-CD45R monoclonal antibodies.

Authors:  M N McCall; D M Shotton; A N Barclay
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

2.  Key developmental transitions in human germinal center B cells are revealed by differential CD45RB expression.

Authors:  Stephen M Jackson; Natessa Harp; Darshna Patel; Jordan Wulf; Erich D Spaeth; Uzoamaka K Dike; Judith A James; J Donald Capra
Journal:  Blood       Date:  2008-12-04       Impact factor: 22.113

3.  CD45 expression by murine B cells and T cells: alteration of CD45 isoforms in subpopulations of activated B cells.

Authors:  K S Hathcock; H Hirano; R J Hodes
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

4.  9-O-Acetylation of sialomucins: a novel marker of murine CD4 T cells that is regulated during maturation and activation.

Authors:  M Krishna; A Varki
Journal:  J Exp Med       Date:  1997-06-02       Impact factor: 14.307

5.  Carbohydrate specificity of IgM autoantibodies to CD45 in systemic lupus erythematosus.

Authors:  P D Fernsten; J K Czyzyk; T Mimura; J B Winfield
Journal:  Mol Biol Rep       Date:  1994       Impact factor: 2.316

Review 6.  The Tn antigen-structural simplicity and biological complexity.

Authors:  Tongzhong Ju; Vivianne I Otto; Richard D Cummings
Journal:  Angew Chem Int Ed Engl       Date:  2011-01-21       Impact factor: 15.336

7.  Epigenetic activation of O-linked β-N-acetylglucosamine transferase overrides the differentiation blockage in acute leukemia.

Authors:  K M Kampa-Schittenhelm; T Haverkamp; M Bonin; V Tsintari; H J Bühring; L Haeusser; G Blumenstock; S T Dreher; T Ganief; F Akmut; B Illing; U A Mau-Holzmann; I Bonzheim; E Schleicher; W Vogel; M M Schittenhelm
Journal:  EBioMedicine       Date:  2020-04-06       Impact factor: 8.143

8.  Identification of amino acids at the junction of exons 3 and 7 that are used for the generation of glycosylation-related human CD45RO and CD45RO-like antigen specificities.

Authors:  R Pulido; S F Schlossman; H Saito; M Streuli
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.